Market Movers, June.17

Dow futures up 29.00 points as of 6:01am

UBS loses lead role in bond deal for Chinese firm in reaction to a pig comment used while referring Chinese food price inflation, Reuters

Commerce Secretary Wilbur Ross says enforcing tariffs is the most important aspect of
China Trade Talks, CNBC reports

6:42am UniQure up 10% on 109 000 shares traded after news they are exploring a sale, Business Insider reports

7:10am Oil down 1.28% on worries about the economy.

“The9 Limited Invests into a Battery Management System Supplier to Continue Developing its Electric Vehicle Eco-chain”, Read more

Treasury yields flat as everybody awaits fed meeting; consensus prediction is 80% for a rate cut this week, CNBC reports

7:28am, ARRY up 58% after Pfizer buyout, read more at SeekingAlpha 

7:48am, RIOT Blockchain up 10% on 38 000 shares traded, Bitcoin exploded almost 1000 points over the weekend, currently $9300 USD

 7:53am, Calithera Biosciences Inc up 11% after reporting positive topline results in randomized phase 2 study, click the image below to read more

8:14am, BYND following through after its Friday rebound, up 7% on 450 000 shares traded

-Fed likely to resist pressures to cut rates
-On Friday the Atlanta Fed forecasted gross domestic product would increase at an annualized rate of 2.1 percent in the April-June quarter, a drop from the 3.1 percent
-“The markets are set up for a cut in July, and if they don’t get it, financial conditions will tighten”, says Carl Tannenbaum, chief economist at Northern Trust. Reuters reports

click the image to view the chart

“Vislink Transmitters and Receivers Deployed at First North American Battle Royale Esports Arena”
up 58% as of 12:00pm, Read more at Globenewswire

Patrick Drahi buys Sotheby’s ($BID) for 2.7 billion, up 58% at noon, Bloomberg reports

CLCI went up as high as $2.50 as crypto heats up.  They are apparently working with Amazon to provide a means to “accelerate transaction speeds while reducing loads on the system” in ethereum payment systems, Read more

CTRV up 42% as of 12:30pm after announcing findings from its first study with human precision cut liver slice cultures. “Co-administration of ContraVir’s clinical phase drug candidate, CRV431, was found to be 100% effective at preventing fibrosis induction beyond baseline levels. CRV431 at clinically relevant concentrations also partially or completely blocked several genetic and protein biomarkers of inflammationRead more

1:15pm, Dow up 51.00 points, but the VIX is up 1.5%.

AMD down 2% but at the top of the volume list



Stay tuned for updates, follow us on twitter!

Leave a Reply

%d bloggers like this: